PMID- 8551683
OWN - NLM
STAT- MEDLINE
DCOM- 19960220
LR  - 20151119
IS  - 0047-1860 (Print)
IS  - 0047-1860 (Linking)
VI  - 43
IP  - 11
DP  - 1995 Nov
TI  - [Hand-mirror cells acute lymphoblastic leukemia (L3)].
PG  - 1173-7
AB  - To our knowledge, this report represents the first confirmed case in Japan of a 
      15-year-old boy with acute lymphoblastic leukemia (ALL).L3 with hand-mirror cells 
      (HMC) in the bone marrow. HMC lymphoid leukemia is an unusual variant of ALL in 
      which the bone marrow lymphoblasts manifest distinctive hand-mirror morphologic 
      features. HMC lymphoblast is characterized by an asymmetric foot-like cytoplasmic 
      process that extends from the portion of the cell, thus giving it the 
      light-microscopic appearance responsible for its name. Besides ALL, HMC has been 
      reported in acute myeloblastic leukemia (AML), blastic crisis of chronic 
      myelogenous leukemia, non-Hodgkin's lymphoma, and infectious mononucleosis. HMC 
      has been reported to be prevalent in ALL.L1 and L2 as compared with L3.
FAU - Uemura, K
AU  - Uemura K
AD  - Central Clinical Laboratory, University of Occupational and Environmental Health, 
      Kitakyusyu.
FAU - Otani, H
AU  - Otani H
FAU - Sakamoto, K
AU  - Sakamoto K
FAU - Sakanishi, Y
AU  - Sakanishi Y
FAU - Ota, T
AU  - Ota T
FAU - Kobayashi, T
AU  - Kobayashi T
FAU - Ariyoshi, N
AU  - Ariyoshi N
FAU - Shirahata, A
AU  - Shirahata A
LA  - jpn
PT  - Case Reports
PT  - English Abstract
PT  - Journal Article
PT  - Review
PL  - Japan
TA  - Rinsho Byori
JT  - Rinsho byori. The Japanese journal of clinical pathology
JID - 2984781R
RN  - 5J49Q6B70F (Vincristine)
RN  - 80168379AG (Doxorubicin)
RN  - 9PHQ9Y1OLM (Prednisolone)
SB  - IM
MH  - Adolescent
MH  - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
MH  - Blast Crisis
MH  - *Bone Marrow Cells
MH  - Doxorubicin/administration & dosage
MH  - Fatal Outcome
MH  - Humans
MH  - Male
MH  - Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy/*pathology
MH  - Prednisolone/administration & dosage
MH  - Remission Induction
MH  - Vincristine/administration & dosage
RF  - 24
EDAT- 1995/11/01 00:00
MHDA- 1995/11/01 00:01
CRDT- 1995/11/01 00:00
PHST- 1995/11/01 00:00 [pubmed]
PHST- 1995/11/01 00:01 [medline]
PHST- 1995/11/01 00:00 [entrez]
PST - ppublish
SO  - Rinsho Byori. 1995 Nov;43(11):1173-7.